Login to Your Account



Xentech Seeks to Fund €4M Development Plan

By James Etheridge


Wednesday, November 12, 2008

No Abstract

 

BioWorld International Correspondent

PARIS - Xentech, a contract research start-up specialized in evaluating the efficacy of anticancer therapies, raised seed capital of €600,000 (US$765,000) from Aurinvest Capital 2, indicating that would help it put together a €4 million development plan.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription